Abstract
Purpose
Acute ischemic stroke induces rapid neuronal death and time is a key factor in its treatment. Despite timely recanalization, malignant cerebral infarction can ensue, requiring decompressive surgery (DC). The ideal timing of surgery is still a matter of debate; in this study, we attempt to establish the ideal time to perform surgery in this population.
Methods
We conducted a retrospective study of patients undergoing DC for stroke at our department. The indication for DC was based on drop in level of consciousness and standard imaging parameters. Patients were stratified according to the timing of DC in four groups: (a) “ultra-early” ≤12 h, (b) “early” >12≤24 h, (c) “timely” >24≤48 h, and (d) “late” >48 h. The primary endpoint of this study was in-house mortality, as a dependent variable from surgical timing. Secondary endpoint was modified Rankin scale at discharge.
Results
In a cohort of 110 patients, the timing of surgery did not influence mortality or functional outcome (p=0.060). Patients undergoing late DC were however significantly older (p=0.008), and those undergoing ultra-early DC showed a trend towards a lower GCS at admission.
Conclusions
Our results add to the evidence supporting an extension of the time window for DC in stroke beyond 48 h. Further criteria beyond clinical and imaging signs of herniation should be considered when selecting patients for DC after stroke to identify patients who would benefit from the procedure.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Acute ischemic stroke (AIS) induces rapid neuronal death, with studies quoting an average of 1.9 million neurons lost per minute of interrupted brain perfusion [19]. Thus, time is a key factor in the treatment of AIS, with current guidelines advocating for the fastest achievable onset-to-treatment time to reduce morbidity and mortality [14]. In fact, studies have shown that for every 15 min reduced in the interval between symptom onset and therapy administration, the odds of a better outcome increase [14, 20]. Hence, if treatment with adequate reperfusion is not timely performed, infarct volume increases, leading to increased disability and mortality.
Despite timely recanalization, malignant cerebral infarction (MCI) with intracranial hypertension resulting from edematous infarcted brain tissue can ensue. In these cases, decompressive craniectomy (DC) is indicated to reduce mortality [22]. Three randomized-controlled trials — DESTINY [9], HAMLET [7], and DECIMAL [23] — provided the evidence to advocate for surgery within the first 48 h after ictus in patients aged 60 years or younger, as stated in international guidelines [16]. Nevertheless, this time window has been debated, with studies showing that patients can benefit from surgical intervention beyond this time span [4]. In this study, we aim to elucidate the optimal time window to perform DC in patients with MCI.
Methods and materials
We conducted a retrospective analysis of patients undergoing DC for MCI at our center between January 2011 and March 2019. Internal review board approval was obtained; the study was carried out in accordance with the 1964 Helsinki declaration.
Patients
Basic demographic and clinical parameters were collected, including sex, age, Glasgow coma scale (GCS), and National Institutes for Health Stroke Scale (NIHSS) scores at presentation, comorbidities such as arterial hypertension (AHT), diabetes mellitus (DM), and hypercholesterolemia, smoking status, and positive past medical history for stroke. To better categorize stroke volume, the Alberta stroke program early CT score (ASPECTS) was applied.
Interventions
Intravenous thrombolysis (IVtPA) was administered to patients if they presented within 3 h of ictus, in compliance with international guidelines [16, 18]. Patients underwent mechanical thrombectomy (MT) of large vessel occlusion (LVO) if they presented within 6 h from ictus, or if they met further criteria for late MT, as outlined in international guidelines [21].
Definitions
MCI was radiologically defined as hypodensity in computed tomography (CT) and/or mismatch in CT-perfusion of more than 50–75% of the middle cerebral artery (MCA) territory, including the basal ganglia, involvement of additional vascular territories, and midline shift. Clinically, MCI was defined as progressive neurological deterioration, supposing a drop of at least two points in GCS score in non-comatose patients.
Surgical indications and strategy
DC was indicated by a senior neurosurgeon and a senior neurologist in interdisciplinary fashion when the aforementioned criteria were met. Of note, no strict time window between symptom onset and therapy was considered when indicating DC. Exclusion criteria for surgery were (a) MCI involving the entire cerebral hemisphere (anterior, middle, and posterior cerebral artery territories); (b) bilateral AIS; (c) bilateral, fixed, dilated pupils. Hemorrhagic transformation of the MCI prior to surgery was not considered a contraindication. Age was not considered an exclusion criterion either, as premorbid performance was taken into account above chronological age alone.
Endpoints and statistical analysis
Patients were stratified according to the timing of DC in four groups: (a) “ultra-early” ≤12 h, (b) “early” >12≤24 h, (c) “timely” >24≤48 h, and (d) “late” >48 h. Means (± standard deviations (SD)) were used to report normally distributed continues variables. Frequencies and percentages were used to report categorical and ordinal variables. The groups were compared by means of an ANOVA test for continuous variables, and through a Chi Square test for categorical ones. The primary endpoint of this study was in-house mortality, as a dependent variable from DC timing. Secondary endpoint was modified Rankin scale (mRS) at discharge. Furthermore, a multivariate regression analysis was performed to assess which factors were associated with in-house mortality. Significance was assumed at p<0.05. Results are reported in odds ratios (OR) and confidence intervals (CI). Statistics were performed with IBM® SPSS® v. 27.
Results
A total of 110 patients were included, of which n=39, 35% perished. Mean age was 60 years (range: 18–84). Baseline characteristics are summarized in Table 1.
Most patients (n=76, 68%) exhibited a significantly decreased level of consciousness (GCS<13). A trend towards severe impairment of consciousness (GCS<9) was observed in patients undergoing ultra-early DC (p=0.074), without it reaching statistical significance. All patients exhibited large infarct volumes at presentation, with a mean ASPECTS of 3 (0–10).
No statistically significant differences were observed in thrombolytic procedures performed, with n=51, 46% of all patients receiving IVtPA, and n=45, 41% undergoing MT.
Of note, patients undergoing late DC were significantly older (mean 67 years, p=0.008) than those undergoing DC within 48 h after symptom onset. Furthermore, most patients undergoing DC between 12 and 48 h were males, while those undergoing ultra-early or late DC were almost equally distributed between male and female. This difference in sex distribution was statistically significant (p=0.049). On the other hand, patients undergoing ultra-early DC did not have AHT as a previously known comorbidity (p=0.002) and had significantly shorter lengths of hospitalization (p=0.018), with a mean of 14 days (SD 9.8).
While no statistical significance was achieved (p=0.060), patients undergoing ultra-early DC and late DC had higher mortality rates of 52% and 43%, respectively. Primary and secondary outcomes are summarized in Table 2. Favorable outcomes of mRS≤3 were observed in a minority of cases, as summarized in Fig. 1. In a multivariable analysis, only previous stroke (p=0.044) was predictive of in-house mortality.
Discussion
Our analysis did not show any statistical differences in mortality or functional outcome in patients undergoing DC for MCI at different time-points after symptom onset; in particular, no benefit from ultra-early DC, within the first 12 h after ictus, could be proven. Similarly, no futility could be proven in performing DC beyond 48 h after ictus. These results raise several questions about the surgical management of AIS and MCI, not only regarding the timing of DC, but also the indications therefor.
Our results add to the body of evidence in favor of extending the time window for DC in MCI. In a meta-analysis of seven studies reporting on 1508 patients, DC after 48 h of ictus was not associated with a higher risk of unfavorable outcome [4].Thus, the classical assumption that DC should be performed within 48 h after ictus should be reevaluated. While the evidence does not suffice to call for a change in the guidelines, the authors advocate for individualized decision-making when selecting patients for DC in MCI beyond 48 h after ictus.
In our cohort, patients undergoing ultra-early DC were admitted with lower GCS scores (mean=8) and comatose, as opposed to those undergoing DC later, who presented with an average GCS>8. Additionally, ASPECTS score at presentation did not differ within the groups, thus underlining the question as to whether surgical indication for DC in AIS should be based on early imaging criteria before a severe clinical deterioration ensues.
Based on our internal protocols, DC is indicated when patients suffer a drop of at least two points in GCS and/or exhibit imaging signs of herniation. In a study of 71 patients with MCI undergoing DC, Mori et al. argue that early DC, before clinical and radiological signs of herniation ensue, can improve functional outcome and reduce mortality in this patient population [12]. However, this approach has been contended in the literature. The HeADDFIRST trial attempted to identify patients with AIS who would benefit from early DC. However, of 40 patients amenable to DC, only 26 developed clinical deterioration [3], thus raising the question as to whether some patients would have undergone an unnecessary procedure with relatively high morbidity [13].
Another finding in our study was that, on average, patients undergoing late DC were significantly older. This is probably due, in part, to brain atrophy and a decreased baseline intracranial pressure (ICP) in elderly patients [15]. A previous study from our group demonstrated that elderly patients with MCI and DC have statistically significantly lower ICP values than their younger counterparts [6]. Thus, we hypothesize that these patients are better able to compensate, at least at an early stage, surges in ICP that would otherwise lead to drops in GCS and thus to a surgical indication in younger patients. This raises a further question as to whether GCS adequately reflects clinical deterioration in elderly patients. Whether elderly patients with AIS and MCI should be considered for DC has also been a matter of debate. The DESTINY II trial [10] showed that elderly patients could benefit from DC to improve mortality and outcome. On the other hand, the DECAP study showed that DC could be a life-saving measure for elderly patients as well, albeit not one positively influencing functional outcome [17].
Future directions
Taken together, our results suggest that the indication and timing of DC in MCI warrant critical reassessment. Emerging evidence in traumatic brain injury, for example, supports the use of computed tomography perfusion (CTP) studies to better assess the level of brain impairment and guide treatment [1, 2, 8]. In stroke, CTP can be used to better identify tissue at risk for further ischemia and edema, and potentially select patients who would benefit from early DC, prior to significant clinical deterioration. Other studies have suggested that the rate at which stroke volume increases might be a good surrogate to predict the need for DC [11]. Clinically, applying the Wessex modified Richmond sedation scale (WMRSS), developed the aim of improving the early identification of MCI patients requiring DC, might aid clinicians in indicating DC, as it has been shown to outperform GCS in DC prediction [5].
On the other hand, elderly patients, due to age-related changes in brain compliance and ICP, appear to behave differently, exhibiting protracted brain swelling and, potentially, later herniation. Thus, selection criteria for these individuals should be further assessed, as clinical deterioration may be a later sign in the disease course of these individuals
Limitations
Due to its retrospective nature, our study is subject to bias. Because of the criteria utilized at our center to indicate DC in MCI, our results can be seen as a self-fulfilling prophecy, for patients in worse neurological condition were operated on sooner. Furthermore, our study does not include long-term follow-up, which might have revealed better functional outcomes, as stroke patients are known to improve after rehabilitation. Additionally, the establishment of MT as an effective treatment for LVO has led to improvement in functional outcome of AIS patients and could have potentially influenced the outcome of subjects included in this analysis after 2015.
Conclusion
Our study did not show any influence of the timing of surgery on mortality and functional outcome in patients undergoing DC for MCI. Our results appear to add to the evidence supporting an extension of the time window for DC in stroke beyond 48 h. Further criteria beyond clinical and imaging signs of herniation should be considered when selecting patients for DC after stroke to timely identify patients who would benefit from the procedure before herniation ensues.
References
Agarwal S, Jones PS, Alawneh JA et al (2011) Does perfusion computed tomography facilitate clinical decision making for thrombolysis in unselected acute patients with suspected ischaemic stroke? Cerebrovasc Dis 32(3):227–233
Bendinelli C, Bivard A, Nebauer S, Parsons MW, Balogh ZJ (2013) Brain CT perfusion provides additional useful information in severe traumatic brain injury. Injury 44(9):1208–1212
Frank JI, Philip Schumm L, Wroblewski K, Chyatte D, Rosengart AJ, Kordeck C, Thisted RA Hemicraniectomy and durotomy upon deterioration from infarction-related swelling trial (HeADDFIRST): a randomized pilot clinical trial. https://doi.org/10.1161/STROKEAHA.113.003200
Goedemans T, Verbaan D, Coert BA, Kerklaan B, Van Den Berg R, Coutinho JM, Van Middelaar T, Nederkoorn PJ, Vandertop WP, Van Den Munckhof P (2020) Outcome after decompressive craniectomy for middle cerebral artery infarction: timing of the intervention. Clin Neurosurg 86(3):E318–E325
Hayat TTA, Myers MA, Hell J, Cordingly M, Bulters DO, Weir N, Pengas G (2018) The Wessex modified Richmond sedation scale as a novel tool for monitoring patients at risk of malignant MCA syndrome. Acta Neurochir 160(6):1115–1119
Hernández-Durán S, Meinen L, Rohde V, von der Brelie C (2021) Invasive monitoring of intracranial pressure after decompressive craniectomy in malignant stroke. Stroke. https://doi.org/10.1161/STROKEAHA.120.032390
Hofmeijer J, Kappelle LJ, Algra A, Amelink GJ, van Gijn J, van der Worp HB (2009) Surgical decompression for space-occupying cerebral infarction (the hemicraniectomy after middle cerebral artery infarction with life-threatening edema trial [HAMLET]): a multicentre, open, randomised trial. Lancet Neurol 8(4):326–333
Huang APH, Tsai JC, Kuo LT et al (2014) Clinical application of perfusion computed tomography in neurosurgery: clinical article. J Neurosurg 120(2):473–488
Jüttler E, Schwab S, Schmiedek P, Unterberg A, Hennerici M, Woitzik J, Witte S, Jenetzky E, Hacke W (2007) Decompressive surgery for the treatment of malignant infarction of the middle cerebral artery (DESTINY): a randomized, controlled trial. Stroke 38(9):2518–2525
Jüttler E, Unterberg A, Woitzik J et al (2014) Hemicraniectomy in older patients with extensive middle-cerebral-artery stroke. N Engl J Med 370(12):1091–1100
Kamran S, Salam A, Akhtar N et al (2018) Factors that can help select the timing for decompressive hemicraniectomy for malignant MCA stroke. Transl Stroke Res 9(6):600–607
Mori K, Nakao Y, Yamamoto T, Maeda M (2004) Early external decompressive craniectomy with duroplasty improves functional recovery in patients with massive hemispheric embolic infarction: timing and indication of decompressive surgery for malignant cerebral infarction. Surg Neurol 62(5):420–429
Mraček J, Mork J, Dostal J, Tupy R, Mrackova J, Priban V (2021) Complications following decompressive craniectomy. J Neurol Surg A Cent Eur Neurosurg 82(5):437–445
Ormseth CH, Sheth KN, Saver JL, Fonarow GC, Schwamm LH (2017) The American Heart Association’s get with the guidelines (GWTG)-stroke development and impact on stroke care. Stroke Vasc Neurol 2(2):94
Pedersen SH, Lilja-Cyron A, Andresen M, Juhler M (2018) The relationship between intracranial pressure and age—chasing age-related reference values. World Neurosurg 110:e119–e123
Powers WJ, Rabinstein AA, Ackerson T et al (2019) Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke a guideline for healthcare professionals from the American Heart Association/American Stroke A. Stroke. https://doi.org/10.1161/STR.0000000000000211
Rahmig J, Wöpking S, Jüttler E, Uhlmann L, Limprecht R, Barlinn J, Schackert G, Reichmann H, Schneider H (2019) Decompressive hemicraniectomy in elderly patients with space-occupying infarction (DECAP): a prospective observational study. Neurocrit Care 31(1):97–106
Ringleb PA, Bousser M, Ford G, Bath P, Brainin M, Caso V, Cervera Á (2008) Guidelines for management of ischaemic stroke and transient ischaemic attack 2008 the European Stroke Organization (ESO) Committee and the ESO Writing Committee Executive. Stroke 25(5):6855–6859
Risitano A, Toni D (2020) Time is brain: timing of revascularization of brain arteries in stroke. Eur Heart J Suppl 22(Supplement_L):L155–L159
Song S, Fonarow GC, Olson DWM et al (2016) Association of get with the guidelines-stroke program participation and clinical outcomes for medicare beneficiaries with ischemic stroke. Stroke 47(5):1294–1302
Turc G, Bhogal P, Fischer U et al (2023) European Stroke Organisation (ESO) - European Society for minimally invasive neurological therapy (ESMINT) guidelines on mechanical thrombectomy in acute ischemic stroke. J Neurointerv Surg 15(8):e8
Vahedi K, Hofmeijer J, Juettler E et al (2007) Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol 6(3):215–222
Vahedi K, Vicaut E, Mateo J et al (2007) Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL Trial). Stroke 38(9):2506–2517
Funding
Open Access funding enabled and organized by Projekt DEAL.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Data collection and evaluation was performed by SHD. The first draft of the manuscript was written by SHD and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethical approval
Ethical approval was obtained by the ethics committee of the University Hospital Goettingen (No. 32/3/23). This study was performed in accordance with the 1964 Declaration of Helsinki and its later amendments.
Conflicts of interest
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Hernández-Durán, S., Hautmann, X., Rohde, V. et al. Surgical timing and indications for decompressive craniectomy in malignant stroke: results from a single-center retrospective analysis. Acta Neurochir 165, 3815–3820 (2023). https://doi.org/10.1007/s00701-023-05817-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00701-023-05817-x